v3.26.1
Consolidated Schedule of Investments - Schedule of Investments 2 (Details) - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Investment, cost $ 89,862,162 $ 89,914,530              
Investments, market value, total 148,635 225,436              
NET ASSETS — 100.0% (447,081) (235,128) $ (444,057) $ 747,259 $ 837,221 $ 1,060,679 $ 1,300,000 $ 30,600,000 $ 94,800,000
Investment, cost 89,862,162 89,914,530              
Investments, fair value 148,635 225,436              
Net assets at end of period (millions) (447,081) (235,128) $ (444,057) $ 747,259 $ 837,221 $ 1,060,679 $ 1,300,000 $ 30,600,000 $ 94,800,000
Investment, Identifier [Axis]: AffiliateInvestmentsMember                  
Investments, market value, total 141,197 167,642              
Investments, fair value 141,197 $ 167,642              
Investment, Identifier [Axis]: AutomotiveMember                  
Investments, market value, total 0                
Investments, fair value $ 0                
Investment, Identifier [Axis]: CDIsRevasumIncSemiconductorEquipmentMember                  
Acquisition date [1],[2],[3]   Nov. 14, 2016              
Investment, shares/par value (in shares) [1],[3] 39,774,889 [4] 39,774,889 [2]              
Investment, cost [1],[3] $ 9,268,218 [4] $ 9,268,218 [2]              
Investments, market value, total [1],[3] $ 0 [4] $ 0 [2]              
Investment, shares/par value (in shares) [1],[3] 39,774,889 [4] 39,774,889 [2]              
Acquisition date [1],[2],[3]   Nov. 14, 2016              
Investment, cost [1],[3] $ 9,268,218 [4] $ 9,268,218 [2]              
Investments, fair value [1],[3] $ 0 [4] $ 0 [2]              
Investment, Identifier [Axis]: CDIsRevasumIncSemiconductorEquipmentMember | Minimum [Member]                  
Acquisition date [1],[3],[4] Nov. 14, 2016                
Acquisition date [1],[3],[4] Nov. 14, 2016                
Investment, Identifier [Axis]: CDIsRevasumIncSemiconductorEquipmentMember | Maximum [Member]                  
Acquisition date [1],[3],[4] Oct. 03, 2022                
Acquisition date [1],[3],[4] Oct. 03, 2022                
Investment, Identifier [Axis]: CommonStockUCTCoatingsIncAdvancedMaterialsMember                  
Acquisition date [3],[4],[5] Apr. 18, 2011 Apr. 18, 2011 [6]              
Investment, shares/par value (in shares) [3],[4],[5] 1,500,000 [7] 1,500,000 [6]              
Investment, cost [3],[4],[5] $ 662,235 [7] $ 662,235 [6]              
Investments, market value, total [3],[4],[5] $ 141,197 [7] $ 167,642 [6]              
Investment, shares/par value (in shares) [3],[4],[5] 1,500,000 [7] 1,500,000 [6]              
Acquisition date [3],[4],[5] Apr. 18, 2011 Apr. 18, 2011 [6]              
Investment, cost [3],[4],[5] $ 662,235 [7] $ 662,235 [6]              
Investments, fair value [3],[4],[5] $ 141,197 [7] $ 167,642 [6]              
Investment, Identifier [Axis]: CommonStockWrightspeedIncAutomotiveMember                  
Acquisition date [1],[3],[4] Jun. 07, 2019 Jun. 07, 2019 [6]              
Investment, shares/par value (in shares) [1],[3],[4] 69,102 [7] 69,102 [6]              
Investment, cost [1],[3],[4] $ 7,460,851 [7] $ 7,460,851 [6]              
Investments, market value, total [1],[3],[4] $ 0 [7] $ 0 [6]              
Investment, shares/par value (in shares) [1],[3],[4] 69,102 [7] 69,102 [6]              
Acquisition date [1],[3],[4] Jun. 07, 2019 Jun. 07, 2019 [6]              
Investment, cost [1],[3],[4] $ 7,460,851 [7] $ 7,460,851 [6]              
Investments, fair value [1],[3],[4] 0 [7] 0 [6]              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsAdvancedMaterialsSectorMember                  
Investments, market value, total 141,197 167,642              
Investments, fair value 141,197 167,642              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsAutomotiveSectorMember                  
Investments, market value, total 0 0              
Investments, fair value $ 0 0              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorNoteEightMember                  
Investment, shares/par value (in shares) [8] 500,000                
Investments, market value, total [8] $ 63 28              
Investment, shares/par value (in shares) [8] 500,000                
Investments, fair value [8] $ 63 28              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorNoteEighteenMember                  
Investment, shares/par value (in shares) [8] 200,000                
Investments, market value, total [8] $ 25 11              
Investment, shares/par value (in shares) [8] 200,000                
Investments, fair value [8] $ 25 11              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorNoteElevenMember                  
Investment, shares/par value (in shares) [8] 1,000,000                
Investments, market value, total [8] $ 127 55              
Investment, shares/par value (in shares) [8] 1,000,000                
Investments, fair value [8] $ 127 55              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorNoteFifteenMember                  
Investment, shares/par value (in shares) [8] 500,000                
Investments, market value, total [8] $ 64 27              
Investment, shares/par value (in shares) [8] 500,000                
Investments, fair value [8] $ 64 27              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorNoteFiveMember                  
Investment, shares/par value (in shares) [8] 750,000                
Investments, market value, total [8] $ 95 41              
Investment, shares/par value (in shares) [8] 750,000                
Investments, fair value [8] $ 95 41              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorNoteFourMember                  
Investment, shares/par value (in shares) [8] 500,000                
Investments, market value, total [8] $ 64 28              
Investment, shares/par value (in shares) [8] 500,000                
Investments, fair value [8] $ 64 28              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorNoteFourteenMember                  
Investment, shares/par value (in shares) [8] 1,000,000                
Investments, market value, total [8] $ 127 55              
Investment, shares/par value (in shares) [8] 1,000,000                
Investments, fair value [8] $ 127 55              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorNoteNineMember                  
Investment, shares/par value (in shares) [8] 400,000                
Investments, market value, total [8] $ 51 22              
Investment, shares/par value (in shares) [8] 400,000                
Investments, fair value [8] $ 51 22              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorNoteNineteenMember                  
Investment, shares/par value (in shares) [8] 700,000                
Investments, market value, total [8] $ 89 38              
Investment, shares/par value (in shares) [8] 700,000                
Investments, fair value [8] $ 89 38              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorNoteOneMember                  
Investment, shares/par value (in shares) [8] 10,961,129                
Investments, market value, total [8] $ 1,393 600              
Investment, shares/par value (in shares) [8] 10,961,129                
Investments, fair value [8] $ 1,393 600              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorNoteSevenMember                  
Investment, shares/par value (in shares) [8] 1,000,000                
Investments, market value, total [8] $ 127 55              
Investment, shares/par value (in shares) [8] 1,000,000                
Investments, fair value [8] $ 127 55              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorNoteSeventeenMember                  
Investment, shares/par value (in shares) [8] 500,000                
Investments, market value, total [8] $ 64 27              
Investment, shares/par value (in shares) [8] 500,000                
Investments, fair value [8] $ 64 27              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorNoteSixMember                  
Investment, shares/par value (in shares) [8] 500,000                
Investments, market value, total [8] $ 64 28              
Investment, shares/par value (in shares) [8] 500,000                
Investments, fair value [8] $ 64 28              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorNoteSixteenMember                  
Investment, shares/par value (in shares) [8] 500,000                
Investments, market value, total [8] $ 64 27              
Investment, shares/par value (in shares) [8] 500,000                
Investments, fair value [8] $ 64 27              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorNoteTenMember                  
Investment, shares/par value (in shares) [8] 500,000                
Investments, market value, total [8] $ 64 27              
Investment, shares/par value (in shares) [8] 500,000                
Investments, fair value [8] $ 64 27              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorNoteThirteenMember                  
Investment, shares/par value (in shares) [8] 500,000                
Investments, market value, total [8] $ 64 27              
Investment, shares/par value (in shares) [8] 500,000                
Investments, fair value [8] $ 64 27              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorNoteThreeMember                  
Investment, shares/par value (in shares) [8] 500,000                
Investments, market value, total [8] $ 63 28              
Investment, shares/par value (in shares) [8] 500,000                
Investments, fair value [8] $ 63 28              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorNoteTwelveMember                  
Investment, shares/par value (in shares) [8] 500,000                
Investments, market value, total [8] $ 64 27              
Investment, shares/par value (in shares) [8] 500,000                
Investments, fair value [8] $ 64 27              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorNoteTwentyMember                  
Investment, shares/par value (in shares) [8] 150,000                
Investments, market value, total [8] $ 19 8              
Investment, shares/par value (in shares) [8] 150,000                
Investments, fair value [8] $ 19 8              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorNoteTwentyOneMember                  
Investment, shares/par value (in shares) [8] 350,000                
Investments, market value, total [8] $ 44 19              
Investment, shares/par value (in shares) [8] 350,000                
Investments, fair value [8] $ 44 19              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorNoteTwoMember                  
Investment, shares/par value (in shares) [8] 1,300,000                
Investments, market value, total [8] $ 165 71              
Investment, shares/par value (in shares) [8] 1,300,000                
Investments, fair value [8] $ 165 71              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorPreferredStockOneMember                  
Investment, shares/par value (in shares) [8] 26,856,187                
Investments, market value, total [8] $ 0 0              
Investment, shares/par value (in shares) [8] 26,856,187                
Investments, fair value [8] $ 0 0              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorTermNoteOneMember                  
Investment, shares/par value (in shares) [8] 3,000,000                
Investments, market value, total [8] $ 381 164              
Investment, shares/par value (in shares) [8] 3,000,000                
Investments, fair value [8] $ 381 164              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsIntraOpMedicalCorpMedicalDevicesSectorTermNoteTwoMember                  
Investment, shares/par value (in shares) [8] 2,000,000                
Investments, market value, total [8] $ 254 110              
Investment, shares/par value (in shares) [8] 2,000,000                
Investments, fair value [8] $ 254 110              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsMedicalCorpMedicalDevicesSectorMember                  
Investment, shares/par value (in shares) [8]                
Investments, market value, total [8] $ 3,535                
Investment, shares/par value (in shares) [8]                
Investments, fair value [8] $ 3,535                
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsMedicalDevicesSectorMember                  
Investments, market value, total [8]   1,523              
Investments, fair value [8]   1,523              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsMember                  
Investments, market value, total 144,732 169,165              
Investments, fair value $ 144,732 169,165              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsRevasumIncSemiconductorEquipmentSectorCDIsMember                  
Investment, shares/par value (in shares) [9] 39,774,889                
Investments, market value, total [9] $ 0 0              
Investment, shares/par value (in shares) [9] 39,774,889                
Investments, fair value [9] $ 0 0              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsSemiconductorEquipmentSectorMember                  
Investment, shares/par value (in shares) 0                
Investments, market value, total 0              
Investment, shares/par value (in shares) 0                
Investments, fair value 0              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsUCTCoatingsIncAdvancedMaterialsSectorCommonStockOneMember                  
Investment, shares/par value (in shares) 1,500,000                
Investments, market value, total $ 141,197 167,642              
Investment, shares/par value (in shares) 1,500,000                
Investments, fair value $ 141,197 167,642              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsWrightspeedIncAutomotiveSectorCommonStockOneMember                  
Investment, shares/par value (in shares) [8] 69,102                
Investments, market value, total [8] $ 0 0              
Investment, shares/par value (in shares) [8] 69,102                
Investments, fair value [8] $ 0 0              
Investment, Identifier [Axis]: ControlledAffiliateInvestmentsWrightspeedIncAutomotiveSectorPreferredStockOneMember                  
Investment, shares/par value (in shares) [8] 60,733,693                
Investments, market value, total [8] $ 0 0              
Investment, shares/par value (in shares) [8] 60,733,693                
Investments, fair value [8] $ 0 0              
Investment, Identifier [Axis]: ControlledInvestmentsMember                  
Investments, market value, total 3,535 1,523              
Investments, fair value $ 3,535 $ 1,523              
Investment, Identifier [Axis]: ConvertibleNoteIntraopMedicalCorpMedicalDevicesSectorNoteEightMember                  
Maturity date [1],[4],[10] Dec. 31, 2026 [7] Dec. 31, 2026 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Acquisition date [1],[4],[10] Feb. 27, 2020 [7] Feb. 27, 2020 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 1,000,000 [7] 1,000,000 [6]              
Investment, cost [1],[4],[10] $ 1,000,000 [7] $ 1,000,000 [6]              
Investments, market value, total [1],[4],[10] $ 127 [7] $ 55 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 1,000,000 [7] 1,000,000 [6]              
Acquisition date [1],[4],[10] Feb. 27, 2020 [7] Feb. 27, 2020 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Investment, cost [1],[4],[10] $ 1,000,000 [7] $ 1,000,000 [6]              
Investments, fair value [1],[4],[10] $ 127 [7] $ 55 [6]              
Investment, Identifier [Axis]: ConvertibleNoteIntraopMedicalCorpMedicalDevicesSectorNoteEighteenMember                  
Maturity date [1],[10] Dec. 31, 2025 [4],[7] Dec. 31, 2026 [2],[6]              
Interest rate [1],[10] 15.00% [4],[7] 15.00% [2],[6]              
Acquisition date [1],[10] Jul. 16, 2021 [4],[7] Jul. 16, 2021 [2],[6]              
Investment, shares/par value (in shares) [1],[10] 500,000 [4],[7] 500,000 [2],[6]              
Investment, cost [1],[10] $ 500,000 [4],[7] $ 500,000 [2],[6]              
Investments, market value, total [1],[10] $ 64 [4],[7] $ 27 [2],[6]              
Investment, shares/par value (in shares) [1],[10] 500,000 [4],[7] 500,000 [2],[6]              
Acquisition date [1],[10] Jul. 16, 2021 [4],[7] Jul. 16, 2021 [2],[6]              
Interest rate [1],[10] 15.00% [4],[7] 15.00% [2],[6]              
Investment, cost [1],[10] $ 500,000 [4],[7] $ 500,000 [2],[6]              
Investments, fair value [1],[10] $ 64 [4],[7] $ 27 [2],[6]              
Investment, Identifier [Axis]: ConvertibleNoteIntraopMedicalCorpMedicalDevicesSectorNoteElevenMember                  
Maturity date [1],[4],[10] Dec. 31, 2026 [7] Dec. 31, 2026 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Acquisition date [1],[4],[10] Mar. 30, 2022 [7] Mar. 30, 2022 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 150,000 [7] 150,000 [6]              
Investment, cost [1],[4],[10] $ 150,000 [7] $ 150,000 [6]              
Investments, market value, total [1],[4],[10] $ 19 [7] $ 8 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 150,000 [7] 150,000 [6]              
Acquisition date [1],[4],[10] Mar. 30, 2022 [7] Mar. 30, 2022 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Investment, cost [1],[4],[10] $ 150,000 [7] $ 150,000 [6]              
Investments, fair value [1],[4],[10] $ 19 [7] $ 8 [6]              
Investment, Identifier [Axis]: ConvertibleNoteIntraopMedicalCorpMedicalDevicesSectorNoteFifteenMember                  
Maturity date [1],[10] Dec. 31, 2025 [4],[7] Dec. 31, 2026 [2],[6]              
Interest rate [1],[10] 15.00% [4],[7] 15.00% [2],[6]              
Acquisition date [1],[10] Jun. 10, 2021 [4],[7] Jun. 10, 2021 [2],[6]              
Investment, shares/par value (in shares) [1],[10] 500,000 [4],[7] 500,000 [2],[6]              
Investment, cost [1],[10] $ 500,000 [4],[7] $ 500,000 [2],[6]              
Investments, market value, total [1],[10] $ 64 [4],[7] $ 28 [2],[6]              
Investment, shares/par value (in shares) [1],[10] 500,000 [4],[7] 500,000 [2],[6]              
Acquisition date [1],[10] Jun. 10, 2021 [4],[7] Jun. 10, 2021 [2],[6]              
Interest rate [1],[10] 15.00% [4],[7] 15.00% [2],[6]              
Investment, cost [1],[10] $ 500,000 [4],[7] $ 500,000 [2],[6]              
Investments, fair value [1],[10] $ 64 [4],[7] $ 28 [2],[6]              
Investment, Identifier [Axis]: ConvertibleNoteIntraopMedicalCorpMedicalDevicesSectorNoteFiveMember                  
Maturity date [1],[4],[10] Dec. 31, 2026 [7] Dec. 31, 2026 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Acquisition date [1],[4],[10] Nov. 12, 2021 [7] Nov. 12, 2021 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 500,000 [7] 500,000 [6]              
Investment, cost [1],[4],[10] $ 500,000 [7] $ 500 [6]              
Investments, market value, total [1],[4],[10] $ 64 [7] $ 27 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 500,000 [7] 500,000 [6]              
Acquisition date [1],[4],[10] Nov. 12, 2021 [7] Nov. 12, 2021 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Investment, cost [1],[4],[10] $ 500,000 [7] $ 500 [6]              
Investments, fair value [1],[4],[10] $ 64 [7] $ 27 [6]              
Investment, Identifier [Axis]: ConvertibleNoteIntraopMedicalCorpMedicalDevicesSectorNoteFourMember                  
Maturity date [1],[4],[10] Dec. 31, 2026 [7] Dec. 31, 2026 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Acquisition date [1],[4],[10] Oct. 06, 2021 [7] Oct. 06, 2021 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 500,000 [7] 500,000 [6]              
Investment, cost [1],[4],[10] $ 500,000 [7] $ 500 [6]              
Investments, market value, total [1],[4],[10] $ 64 [7] $ 27 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 500,000 [7] 500,000 [6]              
Acquisition date [1],[4],[10] Oct. 06, 2021 [7] Oct. 06, 2021 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Investment, cost [1],[4],[10] $ 500,000 [7] $ 500 [6]              
Investments, fair value [1],[4],[10] $ 64 [7] $ 27 [6]              
Investment, Identifier [Axis]: ConvertibleNoteIntraopMedicalCorpMedicalDevicesSectorNoteFourteenMember                  
Maturity date [1],[4],[10] Dec. 31, 2026 [7] Dec. 31, 2026 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Acquisition date [1],[4],[10] Apr. 06, 2022 [7] Apr. 06, 2022 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 350,000 [7] 350,000 [6]              
Investment, cost [1],[4],[10] $ 350,000 [7] $ 350,000 [6]              
Investments, market value, total [1],[4],[10] $ 44 [7] $ 19 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 350,000 [7] 350,000 [6]              
Acquisition date [1],[4],[10] Apr. 06, 2022 [7] Apr. 06, 2022 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Investment, cost [1],[4],[10] $ 350,000 [7] $ 350,000 [6]              
Investments, fair value [1],[4],[10] $ 44 [7] $ 19 [6]              
Investment, Identifier [Axis]: ConvertibleNoteIntraopMedicalCorpMedicalDevicesSectorNoteNineMember                  
Maturity date [1],[4],[10] Dec. 31, 2026 [7] Dec. 31, 2026 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Acquisition date [1],[4],[10] Feb. 28, 2022 [7] Feb. 28, 2022 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 200,000 [7] 200,000 [6]              
Investment, cost [1],[4],[10] $ 200,000 [7] $ 200,000 [6]              
Investments, market value, total [1],[4],[10] $ 25 [7] $ 11 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 200,000 [7] 200,000 [6]              
Acquisition date [1],[4],[10] Feb. 28, 2022 [7] Feb. 28, 2022 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Investment, cost [1],[4],[10] $ 200,000 [7] $ 200,000 [6]              
Investments, fair value [1],[4],[10] $ 25 [7] $ 11 [6]              
Investment, Identifier [Axis]: ConvertibleNoteIntraopMedicalCorpMedicalDevicesSectorNoteNineteenMember                  
Maturity date [1],[10] Dec. 31, 2025 [4],[7] Dec. 31, 2026 [2],[6]              
Interest rate [1],[10] 15.00% [4],[7] 15.00% [2],[6]              
Acquisition date [1],[10] Jul. 31, 2020 [4],[7] Jul. 31, 2020 [2],[6]              
Investment, shares/par value (in shares) [1],[10] 500,000 [4],[7] 500,000 [2],[6]              
Investment, cost [1],[10] $ 500,000 [4],[7] $ 500,000 [2],[6]              
Investments, market value, total [1],[10] $ 64 [4],[7] $ 28 [2],[6]              
Investment, shares/par value (in shares) [1],[10] 500,000 [4],[7] 500,000 [2],[6]              
Acquisition date [1],[10] Jul. 31, 2020 [4],[7] Jul. 31, 2020 [2],[6]              
Interest rate [1],[10] 15.00% [4],[7] 15.00% [2],[6]              
Investment, cost [1],[10] $ 500,000 [4],[7] $ 500,000 [2],[6]              
Investments, fair value [1],[10] $ 64 [4],[7] $ 28 [2],[6]              
Investment, Identifier [Axis]: ConvertibleNoteIntraopMedicalCorpMedicalDevicesSectorNoteOneMember                  
Maturity date [1],[4],[10] Dec. 31, 2026 [7] Dec. 31, 2026 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Acquisition date [1],[4],[10] Oct. 11, 2019 [7] Oct. 11, 2019 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 500,000 [7] 500,000 [6]              
Investment, cost [1],[4],[10] $ 500,000 [7] $ 500,000 [6]              
Investments, market value, total [1],[4],[10] $ 63 [7] $ 27 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 500,000 [7] 500,000 [6]              
Acquisition date [1],[4],[10] Oct. 11, 2019 [7] Oct. 11, 2019 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Investment, cost [1],[4],[10] $ 500,000 [7] $ 500,000 [6]              
Investments, fair value [1],[4],[10] $ 63 [7] $ 27 [6]              
Investment, Identifier [Axis]: ConvertibleNoteIntraopMedicalCorpMedicalDevicesSectorNoteSevenMember                  
Maturity date [1],[4],[10] Dec. 31, 2026 [7] Dec. 31, 2026 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Acquisition date [1],[4],[10] Dec. 31, 2018 [7] Dec. 31, 2018 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 10,961,129 [7] 10,961,129 [6]              
Investment, cost [1],[4],[10] $ 10,961,129 [7] $ 10,961,000 [6]              
Investments, market value, total [1],[4],[10] $ 1,393 [7] $ 600 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 10,961,129 [7] 10,961,129 [6]              
Acquisition date [1],[4],[10] Dec. 31, 2018 [7] Dec. 31, 2018 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Investment, cost [1],[4],[10] $ 10,961,129 [7] $ 10,961,000 [6]              
Investments, fair value [1],[4],[10] $ 1,393 [7] $ 600 [6]              
Investment, Identifier [Axis]: ConvertibleNoteIntraopMedicalCorpMedicalDevicesSectorNoteSeventeenMember                  
Maturity date [1],[10] Dec. 31, 2025 [4],[7] Dec. 31, 2026 [2],[6]              
Interest rate [1],[10] 15.00% [4],[7] 15.00% [2],[6]              
Acquisition date [1],[10] Jul. 12, 2019 [4],[7] Jul. 12, 2019 [2],[6]              
Investment, shares/par value (in shares) [1],[10] 1,300,000 [4],[7] 1,300,000 [2],[6]              
Investment, cost [1],[10] $ 1,300,000 [4],[7] $ 1,300,000 [2],[6]              
Investments, market value, total [1],[10] $ 165 [4],[7] $ 71 [2],[6]              
Investment, shares/par value (in shares) [1],[10] 1,300,000 [4],[7] 1,300,000 [2],[6]              
Acquisition date [1],[10] Jul. 12, 2019 [4],[7] Jul. 12, 2019 [2],[6]              
Interest rate [1],[10] 15.00% [4],[7] 15.00% [2],[6]              
Investment, cost [1],[10] $ 1,300,000 [4],[7] $ 1,300,000 [2],[6]              
Investments, fair value [1],[10] $ 165 [4],[7] $ 71 [2],[6]              
Investment, Identifier [Axis]: ConvertibleNoteIntraopMedicalCorpMedicalDevicesSectorNoteSixMember                  
Maturity date [1],[4],[10] Dec. 31, 2026 [7] Dec. 31, 2026 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Acquisition date [1],[4],[10] Nov. 29, 2021 [7] Nov. 29, 2021 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 500,000 [7] 500,000 [6]              
Investment, cost [1],[4],[10] $ 500,000 [7] $ 500,000 [6]              
Investments, market value, total [1],[4],[10] $ 64 [7] $ 27 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 500,000 [7] 500,000 [6]              
Acquisition date [1],[4],[10] Nov. 29, 2021 [7] Nov. 29, 2021 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Investment, cost [1],[4],[10] $ 500,000 [7] $ 500,000 [6]              
Investments, fair value [1],[4],[10] $ 64 [7] $ 27 [6]              
Investment, Identifier [Axis]: ConvertibleNoteIntraopMedicalCorpMedicalDevicesSectorNoteSixteenMember                  
Maturity date [1],[10] Dec. 31, 2025 [4],[7] Dec. 31, 2026 [2],[6]              
Interest rate [1],[10] 15.00% [4],[7] 15.00% [2],[6]              
Acquisition date [1],[10] Jun. 10, 2022 [4],[7] Jun. 10, 2022 [2],[6]              
Investment, shares/par value (in shares) [1],[10] 700,000 [4],[7] 700,000 [2],[6]              
Investment, cost [1],[10] $ 700,000 [4],[7] $ 700,000 [2],[6]              
Investments, market value, total [1],[10] $ 89 [4],[7] $ 38 [2],[6]              
Investment, shares/par value (in shares) [1],[10] 700,000 [4],[7] 700,000 [2],[6]              
Acquisition date [1],[10] Jun. 10, 2022 [4],[7] Jun. 10, 2022 [2],[6]              
Interest rate [1],[10] 15.00% [4],[7] 15.00% [2],[6]              
Investment, cost [1],[10] $ 700,000 [4],[7] $ 700,000 [2],[6]              
Investments, fair value [1],[10] $ 89 [4],[7] $ 38 [2],[6]              
Investment, Identifier [Axis]: ConvertibleNoteIntraopMedicalCorpMedicalDevicesSectorNoteTenMember                  
Maturity date [1],[4],[10] Dec. 31, 2026 [7] Dec. 31, 2026 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Acquisition date [1],[4],[10] Mar. 25, 2020 [7] Mar. 25, 2020 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 500,000 [7] 500,000 [6]              
Investment, cost [1],[4],[10] $ 500,000 [7] $ 500,000 [6]              
Investments, market value, total [1],[4],[10] $ 64 [7] $ 28 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 500,000 [7] 500,000 [6]              
Acquisition date [1],[4],[10] Mar. 25, 2020 [7] Mar. 25, 2020 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Investment, cost [1],[4],[10] $ 500,000 [7] $ 500,000 [6]              
Investments, fair value [1],[4],[10] $ 64 [7] $ 28 [6]              
Investment, Identifier [Axis]: ConvertibleNoteIntraopMedicalCorpMedicalDevicesSectorNoteThirteenMember                  
Maturity date [1],[4],[10] Dec. 31, 2026 [7] Dec. 31, 2026 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Acquisition date [1],[4],[10] Apr. 20, 2021 [7] Apr. 20, 2021 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 1,000,000 [7] 1,000,000 [6]              
Investment, cost [1],[4],[10] $ 1,000,000 [7] $ 1,000,000 [6]              
Investments, market value, total [1],[4],[10] $ 127 [7] $ 55 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 1,000,000 [7] 1,000,000 [6]              
Acquisition date [1],[4],[10] Apr. 20, 2021 [7] Apr. 20, 2021 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Investment, cost [1],[4],[10] $ 1,000,000 [7] $ 1,000,000 [6]              
Investments, fair value [1],[4],[10] $ 127 [7] $ 55 [6]              
Investment, Identifier [Axis]: ConvertibleNoteIntraopMedicalCorpMedicalDevicesSectorNoteThreeMember                  
Maturity date [1],[4],[10] Dec. 31, 2026 [7] Dec. 31, 2026 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Acquisition date [1],[4],[10] Oct. 29, 2019 [7] Oct. 29, 2019 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 500,000 [7] 500,000 [6]              
Investment, cost [1],[4],[10] $ 500,000 [7] $ 500,000 [6]              
Investments, market value, total [1],[4],[10] $ 63 [7] $ 28 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 500,000 [7] 500,000 [6]              
Acquisition date [1],[4],[10] Oct. 29, 2019 [7] Oct. 29, 2019 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Investment, cost [1],[4],[10] $ 500,000 [7] $ 500,000 [6]              
Investments, fair value [1],[4],[10] $ 63 [7] $ 28 [6]              
Investment, Identifier [Axis]: ConvertibleNoteIntraopMedicalCorpMedicalDevicesSectorNoteTwelveMember                  
Maturity date [1],[4],[10] Dec. 31, 2026 [7] Dec. 31, 2026 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Acquisition date [1],[4],[10] Mar. 08, 2020 [7] Mar. 08, 2020 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 400,000 [7] 400,000 [6]              
Investment, cost [1],[4],[10] $ 400,000 [7] $ 400,000 [6]              
Investments, market value, total [1],[4],[10] $ 51 [7] $ 22 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 400,000 [7] 400,000 [6]              
Acquisition date [1],[4],[10] Mar. 08, 2020 [7] Mar. 08, 2020 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Investment, cost [1],[4],[10] $ 400,000 [7] $ 400,000 [6]              
Investments, fair value [1],[4],[10] $ 51 [7] $ 22 [6]              
Investment, Identifier [Axis]: ConvertibleNoteIntraopMedicalCorpMedicalDevicesSectorNoteTwentyMember                  
Maturity date [1],[10] Dec. 31, 2025 [4],[7] Dec. 31, 2026 [2],[6]              
Interest rate [1],[10] 15.00% [4],[7] 15.00% [2],[6]              
Acquisition date [1],[10] Aug. 28, 2020 [4],[7] Aug. 28, 2020 [2],[6]              
Investment, shares/par value (in shares) [1],[10] 750,000 [4],[7] 750,000 [2],[6]              
Investment, cost [1],[10] $ 750,000 [4],[7] $ 750,000 [2],[6]              
Investments, market value, total [1],[10] $ 95 [4],[7] $ 41 [2],[6]              
Investment, shares/par value (in shares) [1],[10] 750,000 [4],[7] 750,000 [2],[6]              
Acquisition date [1],[10] Aug. 28, 2020 [4],[7] Aug. 28, 2020 [2],[6]              
Interest rate [1],[10] 15.00% [4],[7] 15.00% [2],[6]              
Investment, cost [1],[10] $ 750,000 [4],[7] $ 750,000 [2],[6]              
Investments, fair value [1],[10] $ 95 [4],[7] $ 41 [2],[6]              
Investment, Identifier [Axis]: ConvertibleNoteIntraopMedicalCorpMedicalDevicesSectorNoteTwentyOneMember                  
Maturity date [1],[10] Dec. 31, 2025 [4],[7] Dec. 31, 2026 [2],[6]              
Interest rate [1],[10] 15.00% [4],[7] 15.00% [2],[6]              
Acquisition date [1],[10] Sep. 22, 2021 [4],[7] Sep. 22, 2021 [2],[6]              
Investment, shares/par value (in shares) [1],[10] 500,000 [4],[7] 500,000 [2],[6]              
Investment, cost [1],[10] $ 500,000 [4],[7] $ 500,000 [2],[6]              
Investments, market value, total [1],[10] $ 64 [4],[7] $ 27 [2],[6]              
Investment, shares/par value (in shares) [1],[10] 500,000 [4],[7] 500,000 [2],[6]              
Acquisition date [1],[10] Sep. 22, 2021 [4],[7] Sep. 22, 2021 [2],[6]              
Interest rate [1],[10] 15.00% [4],[7] 15.00% [2],[6]              
Investment, cost [1],[10] $ 500,000 [4],[7] $ 500,000 [2],[6]              
Investments, fair value [1],[10] $ 64 [4],[7] $ 27 [2],[6]              
Investment, Identifier [Axis]: ConvertibleNoteIntraopMedicalCorpMedicalDevicesSectorNoteTwoMember                  
Maturity date [1],[4],[10] Dec. 31, 2026 [7] Dec. 31, 2026 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Acquisition date [1],[4],[10] Oct. 22, 2021 [7] Oct. 22, 2021 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 1,000,000 [7] 1,000,000 [6]              
Investment, cost [1],[4],[10] $ 1,000,000 [7] $ 1,000,000 [6]              
Investments, market value, total [1],[4],[10] $ 127 [7] $ 55 [6]              
Investment, shares/par value (in shares) [1],[4],[10] 1,000,000 [7] 1,000,000 [6]              
Acquisition date [1],[4],[10] Oct. 22, 2021 [7] Oct. 22, 2021 [6]              
Interest rate [1],[4],[10] 15.00% [7] 15.00% [6]              
Investment, cost [1],[4],[10] $ 1,000,000 [7] $ 1,000,000 [6]              
Investments, fair value [1],[4],[10] 127 [7] $ 55 [6]              
Investment, Identifier [Axis]: IntraopMedicalCorpMedicalDevicesSectorMember                  
Investments, market value, total [1],[4],[7],[10] 3,535                
Investments, fair value [1],[4],[7],[10] $ 3,535                
Investment, Identifier [Axis]: InvestmentCompanyFidelityInvestmentsMoneyMarketTreasuryPortfolioClassIMember                  
Investment, shares/par value (in shares) [11] 3,903 [12] 56,271 [13]              
Investment, cost [11] $ 3,903 [12] $ 56,271 [13]              
Investments, market value, total [11] $ 3,903 [12] $ 56,271 [13]              
Investment, shares/par value (in shares) [11] 3,903 [12] 56,271 [13]              
Investment, cost [11] $ 3,903 [12] $ 56,271 [13]              
Investments, fair value [11] 3,903 [12] 56,271 [13]              
Investment, Identifier [Axis]: InvestmentPortfolioMember                  
Investment, cost 89,862,162 89,914,530              
Investments, market value, total 148,635 225,436              
OTHER LIABILITIES IN EXCESS OF OTHER ASSETS — 133.3% (595,716) (460,564)              
NET ASSETS — 100.0% (447,081) (235,128)              
Investment, cost 89,862,162 89,914,530              
Investments, fair value 148,635 225,436              
Net assets at end of period (millions) $ (447,081) $ (235,128)              
Investment, Identifier [Axis]: LynceanTechnologiesIncSemiconductorEquipmentMember                  
Acquisition date [2],[3],[6]   Jul. 03, 2018              
Investment, shares/par value (in shares) [2],[3],[6]   869,792              
Investment, cost [2],[3],[6]   $ 1,000,000              
Investments, market value, total [2],[3],[6]   $ 0              
Investment, shares/par value (in shares) [2],[3],[6]   869,792              
Acquisition date [2],[3],[6]   Jul. 03, 2018              
Investment, cost [2],[3],[6]   $ 1,000,000              
Investments, fair value [2],[3],[6]   0              
Investment, Identifier [Axis]: MedicalDevicesSector                  
Investments, market value, total   1,523              
Investments, fair value   $ 1,523              
Investment, Identifier [Axis]: PreferredStockSeriesAAWrightspeedIncAutomotiveOneMember                  
Acquisition date [1],[3],[4],[7] Jul. 20, 2020                
Investment, shares/par value (in shares) [1],[3],[4] 60,733,693 [7] 60,733,693 [6]              
Investment, cost [1],[3],[4] $ 17,355,887 [7] $ 17,355,887 [6]              
Investments, market value, total [1],[3],[4] $ 0 [7] $ 0 [6]              
Investment, shares/par value (in shares) [1],[3],[4] 60,733,693 [7] 60,733,693 [6]              
Acquisition date [1],[3],[4],[7] Jul. 20, 2020                
Investment, cost [1],[3],[4] $ 17,355,887 [7] $ 17,355,887 [6]              
Investments, fair value [1],[3],[4] $ 0 [7] $ 0 [6]              
Investment, Identifier [Axis]: PreferredStockSeriesAAWrightspeedIncAutomotiveOneMember | Minimum [Member]                  
Acquisition date [1],[3],[4],[6]   Jun. 07, 2019              
Acquisition date [1],[3],[4],[6]   Jun. 07, 2019              
Investment, Identifier [Axis]: PreferredStockSeriesAAWrightspeedIncAutomotiveOneMember | Maximum [Member]                  
Acquisition date [1],[3],[4] Jun. 07, 2019 Jul. 20, 2020 [6]              
Acquisition date [1],[3],[4] Jun. 07, 2019 Jul. 20, 2020 [6]              
Investment, Identifier [Axis]: PreferredStockSeriesBLynceanTechnologiesIncSemiconductorEquipmentMember                  
Acquisition date [3],[4],[7] Jul. 02, 2018                
Investment, shares/par value (in shares) [3],[4],[7] 869,792                
Investment, cost [3],[4],[7] $ 1,000,000                
Investments, market value, total [3],[4],[7] $ 0                
Investment, shares/par value (in shares) [3],[4],[7] 869,792                
Acquisition date [3],[4],[7] Jul. 02, 2018                
Investment, cost [3],[4],[7] $ 1,000,000                
Investments, fair value [3],[4],[7] $ 0                
Investment, Identifier [Axis]: PreferredStockSeriesCIntraopMedicalCorpMedicalDevicesSectorMember                  
Acquisition date [1],[3] Jul. 12, 2013 [4],[7] Jul. 12, 2013 [2],[6]              
Investment, shares/par value (in shares) [1],[3] 26,856,187 [4],[7] 26,856,187 [2],[6]              
Investment, cost [1],[3] $ 26,299,939 [4],[7] $ 26,299,939 [2],[6]              
Investments, market value, total [1],[3] $ 0 [4],[7] $ 0 [2],[6]              
Investment, shares/par value (in shares) [1],[3] 26,856,187 [4],[7] 26,856,187 [2],[6]              
Acquisition date [1],[3] Jul. 12, 2013 [4],[7] Jul. 12, 2013 [2],[6]              
Investment, cost [1],[3] $ 26,299,939 [4],[7] $ 26,299,939 [2],[6]              
Investments, fair value [1],[3] $ 0 [4],[7] $ 0 [2],[6]              
Investment, Identifier [Axis]: TermNoteIntraopMedicalCorpMedicalDevicesSectorNoteOneMember                  
Maturity date [1],[10] Dec. 31, 2025 [4],[7] Dec. 31, 2026 [2],[6]              
Interest rate [1],[10] 8.00% [4],[7] 8.00% [2],[6]              
Acquisition date [1],[10] Feb. 10, 2017 [4],[7] Feb. 10, 2017 [2],[6]              
Investment, shares/par value (in shares) [1],[10] 2,000,000 [4],[7] 2,000,000 [2],[6]              
Investment, cost [1],[10] $ 2,000,000 [4],[7] $ 2,000,000 [2],[6]              
Investments, market value, total [1],[10] $ 254 [4],[7] $ 110 [2],[6]              
Investment, shares/par value (in shares) [1],[10] 2,000,000 [4],[7] 2,000,000 [2],[6]              
Acquisition date [1],[10] Feb. 10, 2017 [4],[7] Feb. 10, 2017 [2],[6]              
Interest rate [1],[10] 8.00% [4],[7] 8.00% [2],[6]              
Investment, cost [1],[10] $ 2,000,000 [4],[7] $ 2,000,000 [2],[6]              
Investments, fair value [1],[10] $ 254 [4],[7] $ 110 [2],[6]              
Investment, Identifier [Axis]: TermNoteIntraopMedicalCorpMedicalDevicesSectorNoteTwoMember                  
Maturity date [1],[10] Dec. 31, 2025 [4],[7] Dec. 31, 2026 [2],[6]              
Interest rate [1],[10] 8.00% [4],[7] 8.00% [2],[6]              
Acquisition date [1],[10] Feb. 28, 2014 [4],[7] Feb. 28, 2014 [2],[6]              
Investment, shares/par value (in shares) [1],[10] 3,000,000 [4],[7] 3,000,000 [2],[6]              
Investment, cost [1],[10] $ 3,000,000 [4],[7] $ 3,000,000 [2],[6]              
Investments, market value, total [1],[10] $ 381 [4],[7] $ 164 [2],[6]              
Investment, shares/par value (in shares) [1],[10] 3,000,000 [4],[7] 3,000,000 [2],[6]              
Acquisition date [1],[10] Feb. 28, 2014 [4],[7] Feb. 28, 2014 [2],[6]              
Interest rate [1],[10] 8.00% [4],[7] 8.00% [2],[6]              
Investment, cost [1],[10] $ 3,000,000 [4],[7] $ 3,000,000 [2],[6]              
Investments, fair value [1],[10] $ 381 [4],[7] $ 164 [2],[6]              
[1] Controlled investments.
[2] Fair Value Level 3 security (-71.9% of net assets).
[3] Non-income producing security.
[4] Fair Value Level 3 security (-32.4% of net assets).
[5] Affiliated issuer.
[6] Restricted security. Fair Value is determined in good faith by Firsthand Capital Management, Inc. ("FCM" or the "Advisor") as the valuation designee under Rule 2a-5 under the 1940 Act, subject to oversight by the Board (see Note 3). At December 31, 2025, we held $169,165 or (71.9)% of net assets) in restricted securities (see Note 2).
[7] Restricted security. Fair Value is determined in good faith by Firsthand Capital Management, Inc. ("FCM" or the "Advisor") as the valuation designee under Rule 2a-5 under the 1940 Act, subject to oversight by the Board (see Note 3). At June 30, 2026, we held $144,732 (or (32.4)% of net assets) in restricted securities (see Note 2).
[8] Controlled Investments.
[9] CDI: CHESS Depositary Interests
[10] Security whose interest accrues until maturity however, based on December 31, 2025 valuation no such interest accrued during period ended December 31, 2025.
[11] The Fidelity Investments Money Market Treasury Portfolio invests primarily in U.S. Treasury securities.
[12] The rate shown is the 7 day annualized yield at June 30, 2026.
[13] The rate shown is the 7 day annualized yield at December 31, 2025